Updates from The Motley Fool

Latest updates on DURECT Corp from Fool.com.


Stock Performance

DRRX vs. S&P 500 | 2 Year Performance
DRRX 1-Day Stock Chart
DRRX 5-Day Stock Chart
DRRX 1-Month Stock Chart
DRRX 3-Month Stock Chart
DRRX 6-Month Stock Chart
DRRX 1-Year Stock Chart
DRRX 2-Year Stock Chart
DRRX 5-Year Stock Chart
View Interactive DRRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about DURECT Corp.
Current Price: $1.20
Prev Close: $1.23
Open: $1.21
Bid: $1.19
Ask: $1.20
Day's Range: $1.19 - $1.27
52wk Range: $0.99 - $3.42
Volume: 543,829
Avg Vol 678,447
Market Cap: $144.63M
P/E (ttm): -5.86
EPS (ttm): -$0.21
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about DURECT Corp.
CAPS Rating 1 out of 5
 
89 Outperform
17 Underperform
CAPS All Stars
 
21 Outperform
7 Underperform

How do you think DURECT Corp will perform against the market?



You pick for DURECT Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

James E. Brown, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for DURECT Corp.

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers